Cargando…
Risk of bleeding with ticagrelor in elderly patients over 75 years old: A systematic review and meta-analysis
BACKGROUND: Bleeding is an untoward outcome in the management of elderly patients with acute coronary syndrome (ACS). Although the potent oral P2Y12 inhibitor, ticagrelor is clinically beneficial, its association with bleeding events in elderly ACS patients (≥75 years) is poorly understood. METHODS:...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568350/ https://www.ncbi.nlm.nih.gov/pubmed/34871206 http://dx.doi.org/10.1097/MD.0000000000027398 |